Holen Sie sich die Stockscreener-App
2.35
9.22%
-0.20
Leap Therapeutics Inc Aktie (LPTX) Neueste Nachrichten
Barclays PLC Has $412,000 Position in ChoiceOne Financial Services, Inc. (NASDAQ:COFS) - Defense World
JPMorgan Chase & Co. Has $3.82 Million Stock Position in iHeartMedia, Inc. (NASDAQ:IHRT) - Defense World
JPMorgan Chase & Co. Has $3.81 Million Stock Position in Coursera, Inc. (NYSE:COUR) - Defense World
Leap Therapeutics’ (LPTX) Buy Rating Reiterated at HC Wainwright - Defense World
JPMorgan Chase & Co. Grows Stake in Thryv Holdings, Inc. (NASDAQ:THRY) - Defense World
Stock Market Movers Today • Top Gainers & Losers - Benzinga
Esophageal Cancer Pipeline Assessment 2024: Therapies, Clinical Trials, Latest FDA, EMA, and PMDA Approvals, Clinical Trials, and Treatment Outlook | Oncolys BioPharma Inc, Genentech, OncoTherapy - The Globe and Mail
Leap Therapeutics' (LPTX) Buy Rating Reiterated at HC Wainwright - MarketBeat
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap? - Yahoo Finance
Undercovered Dozen: Fannie Mae, Civitas Resources, LifeVantage, ZenaTech + - Seeking Alpha
Geode Capital Management LLC Has $847,000 Stock Holdings in Leap Therapeutics, Inc. (NASDAQ:LPTX) - Defense World
Jane Street Group LLC Trims Stock Position in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Leap Therapeutics: A Buy On Near-Term Data Catalysts In Stomach And Colon Cancer (LPTX) - Seeking Alpha
Leap Therapeutics to Participate at the 43rd Annual J.P. Morgan Healthcare Conference - Quantisnow
Reviewing Amarin (NASDAQ:AMRN) and Leap Therapeutics (NASDAQ:LPTX) - Defense World
Some Brain Cells Change with Age, Some Don't: Study - 69News WFMZ-TV
Gastric Cancer Pipeline, Treatment Drugs, Clinical Trials and Companies 2024 (Updated) - openPR
Leap Therapeutics, Inc. (NASDAQ:LPTX) Short Interest Up 50.7% in December - MarketBeat
HighTower Advisors LLC Makes New $65,000 Investment in Leap Therapeutics, Inc. (NASDAQ:LPTX) - Defense World
Candel Therapeutics Shares Leap on Chairman Purchase - MarketWatch
Biliary Tract Cancer Market Expected to Experience Major Growth by 2034, According to DelveInsight - EIN News
Tonix stock jumps on FDA review for pain drug (TNXP:NASDAQ) - Seeking Alpha
Tenaya stock in selloff on gene therapy data (TNYA:NASDAQ) - Seeking Alpha
Neural Therapeutics Announces Changes to Board of Directors and Completion of Debt Settlement - Yahoo Finance
Leap Therapeutics to Participate at Piper Sandler 36th Annual Healthcare Conference - The Eastern Progress Online
Stoke Therapeutics' drug 'zorevunersen' earns FDA breakthrough tag; shares leap - Investing.com Australia
LEAP-012 Combination of Therapies Extends Progression-Free Survival in Intermediate-Stage Hepatocellular Carcinoma - The ASCO Post
Leap Therapeutics CEO to Present at Piper Sandler Healthcare Conference | LPTX Stock News - StockTitan
HC Wainwright Reaffirms Buy Rating for Leap Therapeutics (NASDAQ:LPTX) - Defense World
Microsoft's Azure Chips Promise AI Leap, Taking on Nvidia and AMD in Cloud Tech Race - Yahoo Finance
HCW Biologics Inc. (HCWB): A Strategic Leap with Worldwide Licensing Agreement Sends Stock Up Over 310% - BP Journal
Simplify Asset Management Inc. Acquires 425,626 Shares of Leap Therapeutics, Inc. (NASDAQ:LPTX) - MarketBeat
Balyasny Asset Management L.P. Reduces Stake in Leap Therapeutics Inc - GuruFocus.com
Leap Therapeutics Reports Third Quarter 2024 Financial Results - citybiz
Leap Therapeutics Reports Wider Q3 Loss, Advances Cancer Drug Trials with $62.8M Cash | LPTX Stock News - StockTitan
Liquor, Wine, Beer: Which Comes With the Worst Lifestyle? - 69News WFMZ-TV
Sparked by FDA expansion, Sarepta's Elevidys takes another leap in sales - FiercePharma
Sermonix Pharmaceuticals’ Lasofoxifene Is Well Tolerated, - GlobeNewswire
DKN-01 With Tislelizumab and Chemotherapy in Advanced Gastric or Gastroesophageal Junction Adenocarcinoma - The ASCO Post
Leap Therapeutics, Inc. (NASDAQ:LPTX) Sees Large Decline in Short Interest - MarketBeat
Spero Therapeutics, Inc. (NASDAQ:SPRO) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap? - Yahoo Finance
Payment processor Finix secures $75m in Series C funding - Electronic Payments International
Dyno Therapeutics Forms New Strategic Partnership With Roche To Advance AAV Gene Therapy Vectors For Neurological Diseases - Business Wire
FDA clears Astellas' Vyloy as first claudin 18.2 cancer drug - pharmaphorum
Astellas nabs class-first FDA approval for CLDN18.2 gastric cancer med Vyloy - FiercePharma
Dow Jones notches new record, chip stocks leap higher - Yahoo Finance
Marshall Wace LLP Acquires New Stake in ChromaDex Co. (NASDAQ:CDXC) - Defense World
Profire Energy, Inc. (NASDAQ:PFIE) Shares Sold by Marshall Wace LLP - Defense World
Marshall Wace LLP Makes New Investment in Vivid Seats Inc. (NASDAQ:SEAT) - Defense World
4.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):